Apogee Therapeutics Stock

apogeetherapeutics.comHealthcare / BioTech & PharmaFounded: 2022

Apogee Therapeutics specializes in treatments and pharmaceuticals for those with immunological and inflammatory disorders. Based in San Francisco, the biopharma company researches and develops novel therapies that engineers antibody effectiveness to address patient needs.

Register To Buy and Sell Shares

For more details on financing and valuation for Apogee Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Apogee Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Apogee Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Michael Henderson
Chief Executive Officer

Apogee Therapeutics’ stock FAQs


Can you buy Apogee Therapeutics’ stock?

Apogee Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Apogee Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Apogee Therapeutics’ stock?

Yes, you can sell stock of a private company like Apogee Therapeutics. Forge can help you sell your Apogee Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Apogee Therapeutics’ stock price?

Apogee Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Apogee Therapeutics’ private market stock price with Forge Data.

What is Apogee Therapeutics’ stock ticker symbol?

Apogee Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders

Oversubscribed $149M Series B financing co-led by new investors Deep Track Capital and RTW Investments, LP adds to Series A investment from founding investors Fairmount and Venrock Healthcare Capital Partners earlier this year.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.